SHAREHOLDER ALERT: Khang & Khang LLP Announces An Investigation Of Zimmer Biomet Holdings, Inc. And Encourages Investors With Losses To Contact The Firm

Khang & Khang LLP (the "Firm") announces that it is investigating claims against Zimmer Biomet Holdings, Inc. ("Zimmer Biomet" or the "Company") (NYSE: ZBH) concerning possible violations of federal securities laws.

If you purchased shares of Zimmer Biomet and want more information, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or by e-mail at

The investigation concentrates on whether Zimmer Biomet and certain of its officers and/or directors violated federal securities laws. On October 31, 2016, the Company announced that it was lowering its full-year forecast, to a lower revenue expectation than analysts predicted.

If you have any questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or by e-mail at

This press release may constitute Attorney Advertising in some jurisdictions.

View source version on
Copyright Business Wire 2010

If you liked this article you might like

Don't Get Out of Joint

Zimmer Biomet: Cramer's Top Takeaways

Market Stands at a Make-Or-Break Level: Cramer's 'Mad Money' Recap (Monday 7/17/17)

Zimmer Biomet Stock Jumps After Jana Said to Have Taken Significant Stake

Cramer: We Have Nothing to Distinguish the Stocks Right Now